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1. Introduction 
Diabetes mellitus (DM) is a metabolic disorder resulting from defects in insulin secretion or 
reduced sensitivity of the tissues to insulin action or both [1]. It is characterized by chronic 
high blood glucose that causes glycation of body proteins which could lead to severe 
complications. These complications are classified into acute, sub-acute and chronic. 
Acute complications include hypoglycemia, diabetic ketoacidosis, hyperosmolar and 
hyperglycaemic non-ketotic syndrome while sub acute complications are thirst, polyuria, 
lack of energy, visual blurriness and weight loss. The chronic complications of diabetes 
mellitus include hypertension, neuropathy, nephropathy, retinopathy and diabetic foot 
ulcers which could result in amputation [2]. 
On the basis of aetiology and clinical presentation, diabetes mellitus can be grouped into 
type 1 known as insulin- dependent diabetes mellitus (IDDM) and type 2 also known as non 
insulin-dependent diabetes mellitus (NIDDM). The World Health Organization (WHO) 
recommends that the terms type 1 and type 2 should be reintroduced, because they classify 
the patients on the basis of the pathogenesis and not on the basis of treatment. Type 1 
diabetes mellitus is caused by immunological destruction of pancreatic β cells leading to 
insulin deficiency [3], whereas type 2 diabetes results from defects in insulin secretion or 
rather insulin resistance. It is the most common type of diabetes, afflicting 85-95% of all 
diabetic individuals. It is a prevalent form of the disease and common in individuals over 40 
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years of age. The increasing number of ageing population, consumption of calorie-rich diet, 
obesity and sedentary life style have led to a tremendous increase in the number of diabetes 
mellitus world wide [2]. About 173 million people suffer with this disease. The number of 
people with diabetes mellitus will be more than double over the next 25 years to reach a 
total of 366 million by 2030 [4]. 
The only therapy of type 1 diabetes is the substitution of insulin. Many and diverse 
therapeutic strategies for the treatment of type 2 diabetes are known. Conventional 
treatments include the reduction of the demand for insulin, stimulation of endogenous 
insulin secretion, enhancement of the action of insulin at the target tissues and the inhibition 
of degradation of oligo- and disaccharides. One group of drugs introduced in the 
management of type 2 diabetes is represented by the inhibitors of α-glycosidase [4]. 
In a general manner DM is a group of metabolic disorders characterized by hyperglycemia. 
These metabolic disorders include alterations in carbohydrate, fat and protein metabolisms 
associated with absolute and relative deficiencies in insulin secretion and/or insulin action 
[5]. Insulin is a hormone needed to convert sugar, starch and other food into energy needed 
for daily life. The cause of diabetes continues to be a mystery, although both genetic and 
environmental factors such as obesity and lack of exercise appear to play a part [6]. The 
control of DM normally involves exercise, diet and drug therapy. In the last years there has 
been an increasing demand for natural products with antidiabetic activity, mainly due to the 
side effects associated with the use of insulin and oral hypoglycemic agents [7]. The 
available therapies for diabetes include insulin and oral antidiabetic agents such as 
sulfonylureas, biguanides and α-glycosidase inhibitors. Many of these oral antiabetic agents 
have a number of serious adverse effects [8]. Thus, the management of diabetes without any 
side effects is still a challenge. 
Plants have always been an important source of drugs and many of the currently available 
drugs have been derived directly or indirectly from them. Ethnobotanical reports indicate 
about 1200 plants in the world with anti-diabetic potential [9], of which more than three 
hundred have been reported in the literature referring to a large variety of identified 
chemical substances. The discovery of the widely used hypoglycemic drug, metformin (N,N-
dimethylguanylguanidine) came from the traditional approach through the use of Galega 
officinalis [10]. 
In this regard, several medicinal plants among which are those belonging to the genus 
Morus have been reported to be used in traditional medicine for the treatment of DM. 
Medicinal plants are one of the few therapeutic resources available to most population. 
According to this reality it is essential to search new alternatives for the treatment of DM. 
Several plant species have been studied as potential antidiabetic agents. 
Considering the importance of species of the genus Morus in treatment of diabetes mellitus, 
this chapter is a review of medicinal plants and natural products with hypoglycaemic 
activity from genus Morus and the main methods used in the assessment of hypoglycemic 
potential of these plants. 
Medicinal Plants and Natural Compounds  
from the Genus Morus (Moraceae) with Hypoglycemic Activity: A Review 191 
2. Methods 
With the objective of contributing to these studies, a literature search on the ethnomedical 
information and use of natural products (crude plant extracts, semi-purified fractions and 
chemically defined molecules) from the genus Morus which have already been evaluated 
particularly for hypoglycemic activity was carried out. The keywords used for the literature 
search for this review were Morus, Moraceae, hypoglycemic activity, antidiabetic activity, 
medicinal plants and natural products. The search was carried out using Biological 
Abstracts, Chemical Abstracts, and the data bank of the University of Illinois in Chicago 
NAPRALERT (Acronym for NAtural PRoducts ALERT), updated to December 2011. The 
references found in the search were then studied in detail. Only those plants whose extracts 
and/or isolated constituents that showed clear pharmacological effects with hypoglycemic 
activity in animal models were included in this review. 
3. Results and discussion 
In this section we present some considerations about the Moraceae family, the main species 
from the genus Morus and chemical constituents isolated from species of this genus with 
hypoglycemic activity as well as important methods for assessing the hypoglycemic 
potential of natural products and plant extracts. 
Consultation of various literature sources resulted in the elaboration of a list of some 
active biomolecules of different Morus species and natural products evaluated for 
hypoglycemic activity (Tables 1, 2 and 3). It should be noted that most of the references 
cited are not first-hand observations, but compilations copied from other sources. For 
details on the models or mechanism-based bioassays utilized for selecting crude plant 
extracts, fractions and other preparations for hypoglycemic activity, the original 
references should be consulted. 
3.1. The family Moraceae and the genus Morus 
Moraceae is a family of flowering plants that comprises about 40 genera and over 1000 
species [11]. The genus Morus, is widely distributed in Asia, Europe, North America, South 
America, and Africa, and is cultivated extensively in the eastern, central, and southern Asia 
for silk production. Mulberry (Morus sp.) has been domesticated over thousands of years 
and has been adapted to a wide area of tropical, subtropical, and temperate zones of the 
world [12]. 
Morus is a genus with species of deciduous trees [11]. There are 24 species of Morus and one 
subspecie, with at least 100 known varieties. Mulberry is found from temperate to 
subtropical regions of the Northern hemisphere to the tropics of the Southern hemisphere 
and they can grow in a wide range of climatic, topographic and soil conditions [13]. Some 
species of this genus are widely cultived in many countries, in particular in China and 
Japan, where mulberry is used for its foliage to feed the silkworm [14]. 
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Species of this genus has also been used in folk medicine (especially in Chinese traditional 
medicine) as antiphlogistic, hepatoprotective, hypotensive, antipyretic, analgesic, diuretic, 
expectorant, antidiabetic [14, 15] as well as to treat anemia and arthritis [12]. The leaves of 
mulberry species are consumed in Korea and Japan as anti-hyperglycemic nutraceutical 
food for patients with diabetes mellitus because the leaves are rich in alkaloid components, 
including 1-deoxynojirymicin (1), which is known to be one of the most potent α-
glycosidase inhibitors [16] that decreases blood sugar levels. 
NH
HO
HO
OH
OH
 
Figure 1. Chemical structure of compound (1) isolated from species of Morus. 
This genus contains a variety of phenolic compounds including isoprenylated flavonoids, 
stilbenes, 2-arylbenzopyrans, coumarins, chromones, xanthones and a variety of Diels-Alder 
adduct compounds [14, 17]. Some of these compounds exhibit interesting biological 
properties such as antiphlogistic, antiinflammatory, diuretic, hypotensive effects and some 
are known as phytoalexins [18]. The antioxidant potential of some phenolic compounds of 
Morus alba also been reported in the literature [19].  
The production of mulberry fruits in 2005 was 78,000 tonnes in Turkey and its cultivation in 
Turkey have been known for more than 400 years [20]. 
3.2. Morus alba L. 
Morus alba, known as white mulberry, is a species native to China and now widely 
cultivated in other countries. It has white and purple fruits with a very sweet taste and low 
acidity. Its fruits are perishable and mostly used for fresh consumption. The fruit of white 
mulberry (which is also found in the Eastern United States) is white to pinkish, unlike the 
red or black berries of most other Morus species. According to sources, white mulberry is the 
species that has been used exclusively in Chinese medicine since A.D- 659. The Chinese 
Pharmacopoeia (1985) lists the leaves, root bark, branches, and fruits as ingredients in 
medicinal preparations, but other parts, including the sap and wood ash, are also widely 
used [21]. 
The different parts of this plant have been used in the traditional Chinese medicine for 
many purposes. The white mulberry leaves, an important food for silkworm, are used to 
treat hypertension, arthritis, and the fruit is a diuretic and a tonic agent. The root bark of the 
plant is considered as an important medicine to treat cough, inflammation, diabetes, cancer, 
hepatitis and heart diseases. Previous studies showed that M. alba mainly contained 
polyphenolic constituents including prenylated flavonoids, benzofurans and Diels–Alder 
Medicinal Plants and Natural Compounds  
from the Genus Morus (Moraceae) with Hypoglycemic Activity: A Review 193 
type adducts with various biological activities such as cytotoxicity, antioxidant, inhibition of 
NF-κB, LOX-1, cancer cell invasion and migration, and hepatoprotection. The glycosidase 
inhibitory activity of several alkaloids in M. alba has also been reported [22]. The root is 
astringent and bark is anti-helmintic. Root is one of the constituents of the Chinese drug 
named “Sohaku-hi” which reduces the plasma sugar level in mice. Decorked bark is used 
against chronic bronchitis and emphysema [23]. 
The root bark also contain an alkaloid, 1-deoxynojirimycin (1) that inhibited glycogenolyses, 
glycoprotein, processing and saccharide hydrolysis enzymes whereas its derivatives have 
great therapeutic potential for the treatment of viral infections, diabetes, obesity and cancer 
[21]. Morus alba leaves containing many nutritional components are the best feed for 
silkworms and they have been used in traditional Chinese medicine as an 
antihyperglycemic to treat and to prevent diabetes mellitus. The components are flavones, 
steroids, triterpenes, amino acids, vitamins and other trace minerals. Among the 6 N-
containing sugars isolated, 2-O-α-D-galactopyranosyl-DNJ (GAL-DNJ) and fagomine have 
the most potent antihyperglycemic effects [24]. Table 1 lists some active biomolecules of 
different Morus species with their medicinal properties. 
3.3. Morus bombycis 
This plant is found in China, Japan, Korea and Southern Sakhaline. Root bark contains 
quinones named as Kwanons G and H with hypotensive activity, phytoalexins like Moracin 
A-Z and Albanins A-H with antimicrobial activity. The leaves also contain N-methyl-1-
deoxynojirimycin which is used against diabetes mellitus. This compound is also inhibits 
the infectivity of human immunodeficiency virus [21]. 
3.4. Morus indica L. 
Over the years, medicinal plants and their extracts are gaining importance in the treatment 
of hyperglycemia and diabetes. The extracts of Morus indica, commonly known as mulberry, 
have been reported to possess medicinal properties, including hypoglycemic, hypotensive 
and diuretic activities. The hypoglycemic effect of mulberry leaves or shoot culture extract 
has been demonstrated using streptozotocin-induced diabetic animals [25]. The ethanol 
extract from the leaves of Morus indica showed antiinflammatory activity on carragenan-
induced edema in rats and cotton pellet granuloma models [26]. 
3.5. Morus insignis 
Ethyl acetate and n-butanol-soluble fractions of the leaves of Morus insignis showed a 
significant hypoglycemic activity on streptozotocin (STZ)-induced hyperglycemic rats. From 
these hypoglycemic activity-showing fractions, two new compounds, mulberrofuran U and 
moracin M-3-O-β-D-glucopyranoside were isolated, along with six known compounds (β-
sitosterol, β-sitosterol-3-O-β-glucopyranoside, ursolic acid, moracin M, kaempferol-3-O-β-
glucopyranoside and quercetin-3-O-β-glucopyranoside) [27]. The fungicidal, bactericidal 
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and hypoglycemic activities of leaves of M. insignis have been attributed to benzofurans 
Mulberrofuran U and Moracin M-3'-O-β-D-glucopyranoside [28].  
 
Name of Morus 
species 
Active constituents Plant part 
used 
Medicinal properties 
Morus alba Kwanon I; Kwanon I hexamethyl ether; 
Kwanon I octamethyl ether; 2’-
Hydroxy-2,4,4’-trimethoxychalcone; 2’-
Hydroxy-3’-prenyl-2,4,4’-
trimethoxychalcone III; Mulberrofuran 
T; Kwanon E; Morusin, Mulberrofuran 
D, G, K; Kwanon G, H; Mulberroside 
A; Cis-mulberrosideA; Oxyresveratrol; 
Isoquercetin; Kwanon G; Moracin E, F, 
G and H; Kwanon D, E, F; 
Deoxynojirimycin-1 
Root, stem, 
leaves, fruit 
Astringent, anti-
helmintic, HIV, cough, 
antiinflammatory, 
exudative, high blood 
pressure, diaphoretic, 
purgative, emollient, 
diarhoea, diabetes, 
atherosclerosis, anti-
tumor, hypoglycemia 
Morus australis Australone A; triterpenoid 3β-[(m-
methoxybenzoyl) oxy]-urs-12-en-28-oic 
acid; morusin; Kwanon C; betulinic 
acid; β-amyrin; quercetin; ursolic acid; 
Mulberrofuran D; sanggenols N and O
Root, leaves, 
fruits 
Astringent, anti-
helmintic, purgative, 
antiplatelet 
Morus bombycis N-methyl-1-Deoxynojirimycin; 
Kwanon G, H; Moracin A-Z; Albanins 
A-H; γ-aminobutyric acid; L-
asparagine; L-arginine; L- lysine; 
choline; Mulberrofuran I 
Root, leaves Hypotensive, 
antimicrobial, diabetes, 
HIV, antiphlogistic, 
diuretic 
Morus laevigata Citrulline; hydroxyproline; free amino 
acids 
Fruit Plaster for sores, cools 
the blood 
Morus nigra Deoxynojirimycin Root, leaves, 
fruits 
Diabetes, AIDS, 
purgative, arterial 
pressure, vermifuge, 
cancer 
Morus serrata β-Amyrin acetate; betulinic acid; 
cerylalcohol; quercetin; morin 
Root ----- 
Morus rubra Rubraflavones A, B, C, D Root Anti-dysenteric, 
laxative, purgative, 
vermifuge, urinary 
problems, weakness 
Morus macroura Guangsangons A-N; albafuran C; 
Kwanon J, X, Y; Mulberrofuran G, K, J 
Stem Antiinflammatory, 
antioxidative 
Morus cathayana Sanggenols F, G, H, I, J, K; cathayanon 
A, B 
Root Antiinflammatory, 
hypertension 
Adapted from reference [21]. 
Table 1. Active biomolecules of different Morus species 
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3.6. Morus nigra L. 
Morus nigra, known as black mulberry, is one of the most important species of the genus 
Morus. It has juicy fruits with extraordinary color and a unique, slightly acidic flavor. The 
fruits are 2-3 cm long [12]. 
A medium or small sized tree 6-9 m high, native to West Asia. It is also cultivated in 
Kashmir, Darjeeling, leaves are ovate-cordate, flower dioecious or monoecious, fruits are 
syncarp, ovoid, purple to black, juicy, edible. The root bark is purgative and vermifuge. 
Root has and effect on pancreas and glycogenolysis while its juice reduces the blood sugar 
level in diabetic patient. The root bark extract contains deoxynojirimycin (DNJ), an alkaloid 
which said to be active against AIDS virus. An infusion of leaves causes a drop in blood 
sugar, sometimes diuresis and a reduction of arterial pressure [21]. 
DNJ is a potent source α-glycosidase inhibitor and helpful to establish greater glycemic 
control in type 2 diabetes. Young mulberry leaves taken from top part of branches in 
summer contains the highest amount of DNJ. In a human study, DNJ enriched powder of 
mulberry leaves significantly suppressed elevation of post-prandial glucose. Newly 
developed DNJ enriched powder can be used as a dietary supplement for preventing 
diabetes mellitus [21]. 
Morus nigra and other members of its genus can be grown without protection in many 
countries. The berries, bark and leaves of the black mulberry are all used medicinally, the 
berries for inflammation and to stop bleeding, the bark for toothache, and the leaves for 
snake bites and as an antidote to action poisoning. In Europe, black mulberry leaves have 
been used recently to stimulate insulin production in diabetes. Mulberry contains soluble 
plant chemicals known as bioflavonoids. These powerful antioxidants may be responsible 
for their medicinal properties [29]. 
Morus nigra has been used in folk medicine as an analgesic, diuretic, antitussive, sedative, 
anxiolytic and hypotensive, in addition to its uses in the treatment of a variety of ailments, 
including inflammatory disorders [17]. There are few studies involving the chemical 
composition and evaluation of biological and pharmacological properties of Morus nigra. 
Morusin, the main prenylflavonoid present in the root bark of this specie have been 
investigated in classical models of pain in mice and exhibits a promising antinociceptive or 
analgesic profile [30]. In recent studies, Naderi et al. [29] demonstrated that extracts of 
Morus nigra fruits have a protective action against peroxidative damage to biomembranes 
and biomolecules. Antiinflammatory properties of methylene chloride extract from leaves 
[31] as well as antinociceptive effects [32] were reported. Three new compounds including 
two flavonoids and a new 2-phenylbenzofuran, named morunigrols A-C, together with 
three known compounds albafuran A, albafuran B and mulberrofuran L were isolated from 
the barks of Morus nigra [33]. Two new prenylflavonoids, mornigrol E and mornigrol F 
were isolated from the barks of this specie [34], as well as germanicol, betulinic acid and β-
sitosterol [31]. Figure 2 shows the chemical structures of some chemical constituents isolated 
from species of the genus Morus. 
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Figure 2. Chemical structures of some natural compounds isolated from species of the genus Morus. 
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Botanical 
name 
Origin (Part 
used) 
Use Preparation Via Organism References 
Morus alba Japan (B) Used for 
diabetes 
Decoction Oral Human 
adult 
[42] 
 Japan (C) Used as an 
antidiabetic 
Bark Oral Human 
adult 
[43] 
 Chile (L) Used to treat 
diabetes 
Infusion Oral Human 
adult 
[44] 
 Spain (L) Used as a 
hypoglycemic 
Hot H2O 
extract 
Oral Human 
adult 
[45] 
 Turkey (L) Used for 
diabetes 
Decoction Oral Human 
adult 
[46] 
 Yugoslavia (L) Used for 
diabetes 
Hot H2O 
extract 
Oral Human 
adult 
[47] 
 Peru (L + S) Used as an 
antidiabetic 
Hot H2O 
extract 
Oral Human 
adult 
[48] 
 France (L) Used for 
diabetes 
Hot H2O 
extract 
Oral Human 
adult 
[49] 
Morus lhou Italy (L) Used as an 
antidiabetic 
Infusion Oral Human 
adult 
[50] 
Morus nigra Canary 
Islands (FL) 
Used as a 
hypoglycemic 
Infusion Oral Human 
adult 
[51] 
 Iran (L) Used in diabetes Decoction Oral Human 
adult 
[52] 
 Yugoslavia (L) Used for 
diabetes 
Hot H2O 
extract 
Oral Human 
adult 
[53] 
 Puerto Rico 
(NS) 
Used for 
diabetes 
Hot H2O 
extract 
Oral Human 
adult 
[54] 
 Iran (RB) Used in diabetes Decoction Oral Human 
adult 
[52] 
Morus 
species 
USSR (L) Used for 
diabetes 
mellitus 
Hot H2O 
extract 
Oral Human 
adult 
[55] 
B= barks; C= cortex; F= fruit; FL= flowers; L= leaf; NS= not specified; RB= root bark; S= stem 
Table 2. Ethnomedical information of Morus. 
The leaves of M. nigra are commonly used by women in menopause as a substitute for the 
conventional hormonal replacement therapy, with a similar effect to that obtained after 
estrogen use. Moreover, the leaves are also used by younger women as a reliever of the 
symptoms of the premenstrual tension. The use of M. nigra usually involves the preparation 
of a ‘‘tea’’ (i.e. through decoction or infusion of the leaves) and is reported to ameliorate the 
 Glucose Tolerance 198 
symptoms of menopause, particularly hot flashes, which are related to the sudden 
vasodilatation that causes the feeling of intense heat and redness of the skin, namely the face 
[35]. 
In Brazil, the cultivation of M. nigra began with the Japanese migration into the country, 
adapting well to conditions of climate and soil. In a recent study realized by our research 
group [36], we evaluated the hypoglycemic potential and acute toxicity of the crude ethanol 
extract of the leaves, and we observed that the extract may be considered of low toxicity since 
it did not cause death or alterations on hematological and biochemical parameters in animals. 
 
Botanical 
name 
Origin  
(Part used) 
Activity Extract Dose/concent. Result Referenc
es 
Morus alba Iran (B) Antihyperglycemic Decoction 500.0 mg/kg Inactive [56] 
 Japan (B) α-Glycosidase 
inhibition 
Hot H2O 
extract 
80.0 mg/kg Active [57] 
 South Korea 
(B) 
Hypoglycemic 
activity 
MeOH  
extract 
2.0 mg/kg Inactive [58] 
 China (BR) Antihyperglycemic Hot H2O 
extract 
1.25 mg/kg Active [59] 
 China (BR) Hypoglycemic 
activity 
Hot H2O 
extract 
1.25 mg/kg Active [59] 
 China (BR) Antihyperglycemic H2O extract 2.1 mg/kg Active [59] 
 Japan (C) Glucose transport 
stimulation 
MeOH 
extract 
5.0 mcg/ml Weak 
activity 
[43] 
 Iran (F) Antihyperglycemic Decoction 500.0 mg/kg Inactive [56] 
 Chile (L) Antihyperglycemic Infusion 0.40 g/animal Active [44] 
 Chile (L) Antihyperglycemic Infusion 0.40 g/animal Inactive [44] 
 China (L) Antihyperglycemic Hot H2O 
extract 
200.0 mg/kg Active [60] 
 Egypt (L) Hypoglycemic 
activity 
EtOH 
(100%) 
extract 
Dose not 
stated 
Active [61] 
 Egypt (L) Antihyperglycemic EtOH 
(100%) 
extract 
Dose not 
stated 
Active [61] 
 Egypt (L) Antihyperglycemic Leaf Dose not 
stated 
Active [61] 
 Egypt (L) Antihyperglycemic EtOH 
(100%) 
extract 
Dose not 
stated 
Inactive [61] 
 Iran (L) Antihyperglycemic Decoction 500.0 mg/kg Inactive [56] 
 Iran (L) Hypoglycemic 
activity 
Decoction 500.0 mg/kg Inactive [56] 
 Japan (L) Antihyperglycemic Hot H2O 
extract 
80.0 mg/kg Active [57] 
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Botanical 
name 
Origin  
(Part used) 
Activity Extract Dose/concent. Result Referenc
es 
 Japan (L) Antihyperglycemic Hot H2O 
extract 
200.0 mg/kg Active [60] 
 Roumania 
(L) 
Antihyperglycemic Infusion 150.0 
ml/person 
Active [62] 
 South Korea 
(L) 
Antihyperglycemic Not 
specified 
Dose not 
stated 
Active [63] 
 Zimbabwe 
(L) 
Hypoglycemic 
activity 
EtOH (80%) 
extract 
200.0 mg/kg Active [64] 
 Zimbabwe 
(L) 
Antihyperglycemic EtOH (80%) 
extract 
200.0 mg/kg Active [64] 
 Zimbabwe 
(L) 
Insulin level 
increase 
EtOH (80%) 
extract 
200.0 mg/kg Inactive [64] 
 Japan (L) Antihyperglycemic EtOH (5%) 
extract 
200.0 mg/kg Active [65] 
 Japan (P)  Antihyperglycemic Lyophilized 
extract 
200.0 mg/kg Active [65] 
 Iran (R) Antihyperglycemic Decoction 500.0 mg/kg Inactive [56] 
 China (RB) Hypoglycemic 
activity 
EtOH:H2O 
(1:1) extract
20.0 mg/kg Active [66] 
 Egypt (RB) Antihyperglycemic EtOH (70%) 
extract 
600.0 mg/kg Active [67] 
 South Korea 
(RB) 
Antihyperglycemic H2O extract 1.0 mg/kg Strong 
activity 
[68] 
 China (R) Antihyperglycemic Hot H2O 
extract 
200.0 mg/kg Active [60] 
Morus 
bombycis 
China (NS) Hypoglycemic 
activity 
EtOH (95%) 
extract 
Dose not 
stated 
Active [69] 
Morus 
indica 
India (L) Antihyperglycemic H2O extract 250.0 
mg/animal 
Active [70] 
 India (SC) Antihyperglycemic H2O extract 130.0 
mg/animal 
Active [70] 
Morus 
insignis 
Argentina 
(L) 
Antihyperglycemic EtOH (70%) 
extract 
100.0 mg/kg Active [27] 
 Argentina 
(L) 
Hypoglycemic 
activity 
EtOAc 
extract 
50.0 mg/kg Active [27] 
 Argentina 
(L) 
Hypoglycemic 
activity 
BuOH 
extract 
50.0 mg/kg Active [27] 
 Argentina 
(L) 
Hypoglycemic 
activity 
H2O extract 50.0 mg/kg Active [27] 
 Argentina 
(L) 
Antihyperglycemic EtOAc 
extract 
100.0 mg/kg Active [27] 
 Argentina 
(L) 
Antihyperglycemic BuOH 
extract 
100.0 mg/kg Active [27] 
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Botanical 
name 
Origin  
(Part used) 
Activity Extract Dose/concent. Result Referenc
es 
Morus 
nigra 
Iran (B) Antihyperglycemic Decoction 500.0 mg/kg Active [56] 
 Iran (B) Antihyperglycemic Decoction 500.0 mg/kg Inactive [56] 
 France (L) Hypoglycemic 
activity 
Hot H2O 
extract 
Dose not 
stated 
Active [49] 
 France (L) Hypoglycemic 
activity 
Hot H2O 
extract 
Dose not 
stated 
Active [71] 
 Iran (L) Hypoglycemic 
activity 
EtOH (95%) 
extract 
0.25 mg/kg Inactive [72] 
 Iran (L) Hypoglycemic 
activity 
EtOH (95%) 
extract 
1.0 mg/kg Inactive [72] 
 Iran (L) Antihyperglycemic EtOH (95%) 
extract 
0.25 mg/kg Active [72] 
 Iran (L) Antihyperglycemic EtOH (95%) 
extract 
0.5 mg/kg Active [72] 
 Iran (L) Antihyperglycemic Decoction 500.0 mg/kg Active [56] 
 Iran (L) Hypoglycemic 
activity 
Decoction 500.0 mg/kg Inactive [56] 
 Iran (L) Antihyperglycemic Decoction 500.0 mg/kg Inactive [56] 
 Iran (RB) Antihyperglycemic Decoction 500.0 mg/kg Inactive [56] 
Morus 
species 
India (L) Antihyperglycemic EtOH (95%) 
extract 
0.5 ml/animal Inactive [73] 
 India (L) Hypoglycemic 
activity 
EtOH (95%) 
extract 
0.5 ml/animal Equivocal [73] 
 India (L) Antihyperglycemic EtOH (95%) 
extract 
0.5 ml/animal Equivocal [73] 
 USSR (L) Antihyperglycemic Tincture Dose not 
stated 
Active [55] 
 Japan (L) Antihyperglycemic Infusion 150.0 mg/kg Active [74] 
B= barks; BR= branches; C= cortex; F= fruit; FL= flowers; L= leaf; NS= not specified; P= protoplasts; R= root; RB= 
rootbark; S= stem; SC= shoot culture 
Table 3. Biological activities for extracts of Morus. 
3.7. Methods for evaluation of hypoglycemic activity of medicinal plants 
3.7.1. Oral glucose tolerance test 
The oral glucose tolerance test is a fast and inexpensive technique and allows you to check 
the effects of drugs on glucose metabolism. In normoglycemic rats, the increase of post-
prandial glucose level, after glucose load, and the consequent standardization to baseline 
levels after about 2 h, characterizes a normal metabolism of glucose. The oral glucose 
tolerance test is an acute methodology for evaluating the resistance of the body to absorb 
glucose and reduce blood glucose levels. Therefore, it’s a method to perform a screening of 
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drugs with potential hypoglycemic action, but with a profile in the absorption of glucose 
(type 2 DM) and not in the production of insulin (type 1 DM) [37]. 
In this experiment, normal Wistar rats are fasted overnight. They are divided into three 
groups containing six animals each. 
Control rats (Group I) are given 1 ml distilled water orally. Extracts of plants in different 
concentrations (mg/kg body weight) are administered orally using a syringe to second and third 
groups. Glucose (2 g/kg b.wt.) is given orally using a syringe to all groups immediately after the 
extracts administration. Blood samples are collected from the tail vein just prior to and 30, 60, 
120 and 240 min after the glucose loading and serum glucose levels are measured [38]. 
3.7.2. Alloxan-induced diabetic rats 
Alloxan induces “chemical diabetes” in a wide variety of animal species by damaging the 
insulin secreting pancreatic β-cell, resulting in a decrease in endogenous insulin release [39]. 
Numerous studies demonstrated that a variety of plant extracts effectively lowered the 
glucose level in alloxan-induced diabetic animals. Alloxan produces oxygen radicals in the 
body, which cause pancreatic injury which is responsible for increased blood sugar seen in 
the animals. However, it is found that action is not specific to pancreas as other organs such 
as liver, kidney and haemopoietic system are also affected by alloxan administration as seen 
from the elevation of marker enzymes and reduction of hematological parameters [40]. 
In this experiment, diabetes is induced in male rats by single intraperitonial injection of 120 
mg/kg b.wt. of alloxan monohydrate. Serum glucose level is checked after 72 h. Animals 
with serum glucose levels >250 mg/dl are considered diabetic and are used for the study. 
The rats are divided into four groups of six rats each. Both group I control normal rats (no 
alloxan treatment) and group II diabetic animals are given 1 ml of distilled water. Group III 
and IV are given the extracts orally in different doses on 3rd day after alloxan treatment. 
Overnight fasted blood samples are collected from the tail vein on 3rd day of alloxan 
treatment prior to and at 2, 4, 6 and 8 h intervals after the administration of the extract 
orally. Serum is separated and glucose levels are estimated as before [38]. 
3.7.3. Streptozotocin-induced diabetic rats 
Streptozotocin (STZ) at low dose for Wistar rats induces light damage to islet cells, leading 
to glucose intolerance. Previous studies have showed that STZ-induced diabetic rats had 
low production of insulin and high levels of blood circulating glucose, which were similar to 
those found in diabetic humans. The precise mechanisms responsible for this defect remain 
unknown. 
Male rats weighing 150-200 g are used in the study and type 2 diabetes is induced. The rats 
are fed with high fat diet (diet containing 74% carbohydrate, 22% protein and 4% fat, 
formulated as 60% total energy is derived from fat) for 15 days except normal control rats 
and then injected with streptozotocin (40 mg/kg). Five days after injection, the rats are fasted 
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and the plasma glucose levels are estimated; rats having plasma glucose levels ≥300 mg/dl 
are taken for further studies with administration of plant extracts. The rats are fed with high 
fat diet throughout the experimental period [41]. 
4. Conclusion 
Diabetes mellitus is a public health problem worldwide. Ethnomedical informations and the 
scientific knowledge of the hypoglycemic activity of species of Morus demonstrate the 
potential of these species in the treatment of diabetes. In vivo testing has become an 
important tool in the search for new antidiabetic agents. The present work showed that 
therapy with species from the genus Morus traditionally used in many countries could be a 
possibility to treat diabetes. On the other hand, medicinal plants contain an enormous 
potential for the development of new antidiabetic drugs. In conclusion, the present study 
provides data which suggest that therapy with mulberry is capable of enhancing glycemic 
control in patients with diabetes. 
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